Patients Professionals Investors Distributors
For Patients

Anticoagulants (Coumadin®, Jantoven®, Warfarin)
Often referred to as “blood thinners”, anticoagulants don’t actually thin the blood, but rather alter the blood’s clotting process. They are prescribed for people with mechanical heart valves, atrial fibrillation or any condition where prevention of a harmful clot is desired. However, over-anticoagulating the blood can also increase risks associated with excessive bleeding. Therefore, patients are frequently monitored to measure the rate at which their blood clots using a Prothrombin Time or PT/INR test. INR stands for International Normalized Ratio and is the most commonly used measurement for this test. Maintaining a PT/INR level in a physician directed therapeutic range is important for maintaining a healthy lifestyle and reducing complications.

Patient Self Testing
Studies show that patients who self test may spend more time in therapeutic range, because they can more rapidly identify trends. This allows for appropriate dose adjustments when advised by a physician. "In order to achieve time in therapeutic range of >90%, a patient most likely needs to be tested once a week." -CMS (Medicare) Decision Memorandum CAG#0087N.

HemoSense
HemoSense was founded in 1997 with the goal of making PT/INR testing simple, accurate and reliable. The INRatio Monitor was introduced in 2003 and is the monitor of choice for thousands of medical professionals and patients.

The INRatio PT/INR Monitor
The easy to use INRatio monitor revolutionized the PT/INR monitor industry with its compact size, non-refrigerated test strip technology and simple 1-2-3 test procedure. Today, INRatio is a leading choice for patients who choose to self-test their PT/INR levels.

Our Product Product Availability Learn About Stories & Profiles Get Help
Home Company Contact